MAS-FRANCE

MAS-FRANCE SAS is developing LifeSeal™ to address the identified absence of a universal monitoring protocol after an official declaration of death and before any irreversible procedure. The protocol is the core of the project: six hours of structured monitoring intended to identify unexpected biological signals and trigger reassessment by an authorized professional. The LifeSeal family comprises three applications: hospital monitoring after death declaration, LifeSeal Home™ for families, and a version for mass-casualty disasters. The programme has reached an advanced stage of development, with an operational digital platform, physical ring integration and controlled engineering tests. Traceability, data security, ethical governance and medical authority underpin the entire system.